PEN
Penumbra Inc
Latest Form 4:Sale$33KbyGrewal Harpreet (Director) · filed Apr 6, 2026
Penumbra Inc (PEN) has 45 SEC Form 4 filings (99 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 19, 2026.
The most active filer is Director Grewal Harpreet with 6 filings. Insiders have net sold $865K over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Adam Elsesser
- Employees:4,600
- HQ:Alameda, CA, US
- IPO:2015-09-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$15.8M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$12.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 100 | $33K | Apr 6 | SEC ↗ | |
Yuen MaggieFirst in 3 months | Chief Financial Officer | Sale | 2,432 | $832K | Mar 4 | SEC ↗ |
| Director | Sale | 186 | $58K | Jan 8 | SEC ↗ | |
Wilder ThomasFirst in 3 months | Director | Sale | 186 | $58K | Jan 6 | SEC ↗ |
| Director | Sale | 15,000 | $4.6M | Dec 15 | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 300 | $90K | Dec 9 | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 600 | $177K | Dec 3 | SEC ↗ | |
| Director | Sale | 100 | $29K | Dec 3 | SEC ↗ | |
| Director | Sale | 7,500 | $2.3M | Nov 26 | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 1,800 | $540K | Nov 26 | SEC ↗ | |
Bose AraniFirst filing | Director | Sale | 7,500 | $2.2M | Nov 25 | SEC ↗ |
| EVP, Gen. Counsel & Secretary | Sale | 600 | $160K | Nov 12 | SEC ↗ | |
| Director | Sale | 186 | $42K | Nov 6 | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 600 | $150K | Oct 3 | SEC ↗ | |
| Director | Sale | 186 | $46K | Oct 3 | SEC ↗ | |
Wilder ThomasFirst filing | Director | Sale | 186 | $47K | Oct 3 | SEC ↗ |
Elsesser AdamFirst filing | CEO | Sale | 15,800 | $4.3M | Sep 4 | SEC ↗ |
Roberts JohannaFirst filing | EVP, Gen. Counsel & Secretary | Sale | 600 | $162K | Sep 4 | SEC ↗ |
Grewal HarpreetFirst filing | Director | Sale | 186 | $51K | Sep 4 | SEC ↗ |
Related companies
Penumbra Inc is in the Healthcare sector.